Susquehanna International Group’s Coeptis Therapeutics Warrants COEPW Stock Holding History

Susquehanna International Group’s Portfolio COEPW Stock Details COEPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-54,681	Closed	-$1.57K	–	12577
2025 Q2	$1.57K	Buy	+54,681	New	+$1.2K	﹤0.01%	12499
2023 Q2	–	Sell	-100,139	Closed	-$14.7K	–	12190
2023 Q1	$14.7K	Buy	+100,139	New	+$12.9K	﹤0.01%	12126
2022 Q4	–	Sell	-37,404	Closed	-$1K	–	12558
2022 Q3	$1K	Sell	37,404 -23,461	-39%	-$1.13K	﹤0.01%	12987
2022 Q2	$2K	Buy	+60,865	New	+$4.57K	﹤0.01%	12686
2021 Q3	–	Sell	-11,382	Closed	-$6K	–	12802
2021 Q2	$6K	Buy	+11,382	New	+$5.79K	﹤0.01%	12453

Other funds holding COEPW

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

SIA

SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return

LCM

Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return

HHGC

Hunting Hill Global Capital New York $129M AUM 17.34% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Susquehanna International Group's COEPW Position: Q3 2025 in Review

Susquehanna International Group sold out of Coeptis Therapeutics Warrants (COEPW) in Q3 2025, closing a stake of 54,681 shares — an estimated $1.57K sold.

Susquehanna International Group first reported a position in COEPW in Q2 2021 and held it in 5 quarters. The position peaked at $14.7K in Q1 2023. 11 funds tracked by Wall St. Rank hold COEPW as of Q3 2025.

Susquehanna International Group reported no remaining Coeptis Therapeutics Warrants position as of Q3 2025 after selling out during the quarter.
Susquehanna International Group sold 54,681 Coeptis Therapeutics Warrants shares in Q3 2025, an estimated $1.57K.
Susquehanna International Group first reported a position in Coeptis Therapeutics Warrants in Q2 2021 and held it in 5 quarters.
Susquehanna International Group's Coeptis Therapeutics Warrants position peaked at $14.7K in Q1 2023.
11 funds tracked by Wall St. Rank held Coeptis Therapeutics Warrants as of Q3 2025.

Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.